• DENTSPLY SIRONA recently announced it will expand its U.S. distribution footprint by adding its full suite of connected digital dentistry technologies, including CEREC, Primescan intraoral scanners, and digital imaging, to Nashville Dental Inc.’s portfolio across a nine-state territory from August 1, 2026.
• This partnership deepens DENTSPLY SIRONA’s mix of direct and distributor-led channels, tying advanced digital workflows to localized installation, service, and practice advisory support for dental practices.
• We’ll now examine how expanding access to DENTSPLY SIRONA’s connected digital solutions through Nashville Dental could influence the company’s broader investment narrative.

The future of work is here. Discover the 33 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

DENTSPLY SIRONA Investment Narrative Recap

To own DENTSPLY SIRONA, you need to believe its push into integrated digital dentistry can eventually offset weak growth, recent losses, and tariff pressure. The Nashville Dental expansion modestly supports the key short term catalyst of broader digital adoption in the U.S., but does little to reduce execution risks around reigniting top line growth and avoiding further impairments after a difficult 2025.

The most relevant recent announcement is the renewed distribution agreement with Patterson Dental, which also broadens access to CEREC, Primescan, and DS Core across the U.S. Together with Nashville Dental, this reinforces the company’s effort to deepen a hybrid direct and distributor go to market model, a critical piece of the bullish catalyst around higher utilization of its connected digital workflows and potential improvement in margins over time.

But while this expanded distribution sounds encouraging, investors should still be aware of the risk that persistent U.S. sales weakness and tariff headwinds could...

DENTSPLY SIRONA's narrative projects $3.7 billion revenue and $161.6 million earnings by 2029.

Uncover how DENTSPLY SIRONA's forecasts yield a $14.54 fair value, a 47% upside to its current price.

Exploring Other Perspectives

Compared with consensus, the lowest analysts took a far more pessimistic stance, assuming only about US$3.7 billion of revenue and roughly US$109 million of earnings by 2029, and they worried that competitive, lower cost digital options could blunt the impact of new partners like Nashville Dental, so it is worth recognizing how differently people can view the same stock and seeing how these expectations might shift as fresh news is absorbed.

Explore 3 other fair value estimates on DENTSPLY SIRONA - why the stock might be worth over 4x more than the current price!

Decide For Yourself

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your DENTSPLY SIRONA research is our analysis highlighting 3 key rewards that could impact your investment decision.
• Our free DENTSPLY SIRONA research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate DENTSPLY SIRONA's overall financial health at a glance.

Seeking Other Investments?

Our daily scans reveal stocks with breakout potential. Don't miss this chance:

• Capitalize on the AI infrastructure supercycle with our selection of the 48 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• This technology could replace computers: discover 30 stocks that are working to make quantum computing a reality.
• Rare earth metals are the new gold rush. Find out which 28 stocks are leading the charge.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.